Abstract
In this project, we aimed to establish osteopontin levels by means of ELISA method, in patients with advanced, unresecable, head and neck cancer. Osteopontin levels, before and after induction chemotherapy with cisplatin combined to radiotherapy will be correlated with clinical pathological parameters.